64 results on '"Elisaf, M"'
Search Results
2. Hypertriglyceridemia, remnant cholesterol and cardiovascular risk: what genes can say
3. Ankle-brachial index long-term outcome after first-ever ischaemic stroke
4. Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia
5. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension
6. Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome
7. Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance
8. Medication-induced hypophosphatemia: a review
9. Does intensive cholesterol lowering increase the risk of diabetes?
10. Cola soft drinks and hypokalaemia
11. Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose
12. Effects of orlistat, alone or combined with hypolipidemic drugs, on cardiovascular risk factors
13. Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implications
14. ASSOCIATION BETWEEN TYPE D PERSONALITY AND THE METABOLIC SYNDROME
15. Blood pressure drug therapy and electrolyte disturbances
16. Sibutramine-associated adverse effects: a practical guide for its safe use
17. Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis
18. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
19. Increased plasma visfatin levels in subjects with the metabolic syndrome
20. Ezetimibe-associated adverse effects: what the clinician needs to know
21. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis
22. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis
23. Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects
24. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects
25. Statins for non-alcoholic fatty liver disease: a new indication?
26. Statins: another class of antihypertensive agents?
27. The control of dyslipidemia in out Patlent clinics in Greece (OLYMPIC) Study
28. Diagnosis and management of the metabolic syndrome in obesity
29. Serum uric acid levels and risk for acute ischaemic nonembolic stroke in elderly subjects
30. Pathogenesis, detection and treatment of Achilles tendon xanthomas
31. Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia: 90
32. Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndrome: 10
33. Serum potassium and acid-base parameters in severe dialysis-associated hyperglycemia treated with insulin therapy
34. Prevention and Treatment of the Metabolic Syndrome
35. Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease
36. Visceral leishmaniasis resembling systemic lupus erythematosus
37. Serum tonicity, extracellular volume and clinical manifestations in symptomatic dialysis-associated hyperglycemia treated only with insulin
38. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
39. Fenofibrate and losartan
40. Lipoprotein (a) and acute-phase response in patients with vestibular neuronitis
41. Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs
42. CHANGES IN SERUM LIPID PARAMETERS -INCLUDING LP(A)- DURING A DIALYSIS SESSION
43. The hyponatremic patient: A systematic approach to laboratory diagnosis
44. Spectrum of autoimmunity and dysproteinemia in patients with visceral leishmaniasis
45. Pinpoint skin lesions in a familial hypercholesterolaemia homozygote
46. Marked hyperphosphataemia in a patient with diabetic ketoacidosis
47. Genetic polymorphisms of the apolipoprotein A-IV in a Greek population and their relation to plasma lipid and lipoprotein levels
48. Fibrate-induced increase in serum urea and creatinine levels
49. Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels
50. Fibrate treatment can increase serum creatinine levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.